|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.60 EUR | +4.51% |
|
+6.47% | -23.50% |
| Jul. 08 | Carl Zeiss Meditec back in demand: Metzler cites signs of recovery | DP |
| Jul. 07 | CARL ZEISS MEDITEC AG : Bernstein sticks Neutral | ZD |
Evolution of the Average Target: Carl Zeiss Meditec AG
Evolution of the Target Price: Carl Zeiss Meditec AG
Changes in Analyst Recommendations: Carl Zeiss Meditec AG
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | -6.44% | |||||
| +12.09% | |||||
| +38.12% | |||||
| +21.71% | |||||
| +64.98% | |||||
| +6.2% | |||||
| +33.42% | |||||
| +18.56% | |||||
| +8.15% | |||||
| +25.6% | |||||
| Average | +22.24% | |||||
| Weighted average by Cap. | +24.98% |
Analysts' Consensus
Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
| BERNSTEIN RESEARCH | Susannah Ludwig |
| GOLDMAN SACHS | Richard Felton |
| alphavalue | Anas Patel |
| JPMORGAN | David Adlington |
| UBS | Graham Doyle |
| RBC | Charles Weston |
| BARCLAYS | Jonathon Unwin |
| DZ BANK | Sven Kürten |
| BERENBERG | Sam England |
| RBC Capital Markets | |
| DEUTSCHE BANK RESEARCH | Falko Friedrichs |
| HAUCK AUFHÄUSER INVESTMENT BANKING | Alexander Galitsa |
| HSBC | |
| Equita SIM | |
| BANK OF AMERICA (BOFA) | Julien Ouaddour |
| HAUCK AUFHÄUSER LAMPE | Alexander Galitsa |
| DEUTSCHE BANK | Falko Friedrichs |
| KEPLER CHEUVREUX | Oliver Reinberg |
| NORDLB | Holger Fechner |
| HAUCK & AUFHÄUSER | Aliaksandr Halitsa |
| INDEPENDENT RESEARCH | Tobias Gottschalt |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AFX Stock
- Consensus Carl Zeiss Meditec AG
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
